Future Science Group

Bioanalysis Zone Roundtable Panel Discussion: Part 2 Pharma and CRO Investment

Informações:

Synopsis

In part 2 of this panel discussion, the panelists discuss the divide between investments being made by Pharma and CROs in new bioanalytical techniques and technologies. Discussions include: Investments made by Pharma and CROs for new constructs Is there a real divide between CRO and Pharma? If so, why is this occurring? What are the gaps? What are the solutions?